Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
grade C 44.99 -3.54% -1.65
EXAS closed down 3.54 percent on Thursday, February 22, 2018, on 1.13 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.
18 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Flat Down Down
See historical EXAS trend table...

Date Alert Name Type % Chg
Feb 22 MACD Bearish Signal Line Cross Bearish 0.00%
Feb 22 200 DMA Support Bullish 0.00%
Feb 22 Earnings Movers Other 0.00%
Feb 22 Wide Bands Range Expansion 0.00%
Feb 22 Below Lower BB Weakness 0.00%
Feb 22 Down 3 Days in a Row Weakness 0.00%
Feb 22 Down 4 Days in a Row Weakness 0.00%
Feb 22 Lower Bollinger Band Touch Weakness 0.00%
Feb 22 Oversold Stochastic Weakness 0.00%
Feb 21 Wide Bands Range Expansion -3.54%

Older signals for EXAS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Is EXAS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 63.6
52 Week Low 19.91
Average Volume 2,666,799
200-Day Moving Average 44.944
50-Day Moving Average 50.7035
20-Day Moving Average 48.2315
10-Day Moving Average 47.228
Average True Range 2.3955
ADX 36.31
+DI 11.16
-DI 31.44
Chandelier Exit (Long, 3 ATRs ) 45.4235
Chandelier Exit (Short, 3 ATRs ) 51.1965
Upper Bollinger Band 51.5052
Lower Bollinger Band 44.9578
Percent B (%b) 0.0
BandWidth 13.574946
MACD Line -1.1716
MACD Signal Line -1.1404
MACD Histogram -0.0312
Fundamentals Value
Market Cap 5.36 Billion
Num Shares 119 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -34.88
Price-to-Sales 34.69
Price-to-Book 10.86
PEG Ratio -1.87
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 49.10
Resistance 3 (R3) 49.53 48.58 48.42
Resistance 2 (R2) 48.58 47.54 48.37 48.19
Resistance 1 (R1) 46.79 46.89 46.32 46.36 47.96
Pivot Point 45.84 45.84 45.61 45.63 45.84
Support 1 (S1) 44.05 44.80 43.58 43.62 42.02
Support 2 (S2) 43.10 44.15 42.89 41.79
Support 3 (S3) 41.31 43.10 41.57
Support 4 (S4) 40.88